iRhythm Holdings, Inc. Common Stock (IRTC) Financials
Key financial figures for iRhythm Holdings, Inc. Common Stock (Q3 2026).
Q3 2026 revenue rose 14.9% to $221.6 million with adjusted EBITDA of $51.2 million, while a $49.8 million litigation settlement charge drove a GAAP net loss of $29.9 million. Revenue was $221.6 million, up 14.9% from $192.9 million a year earlier, driven by Zio Monitor volume across cardiology, primary care, innovative channels and international markets. Gross margin was 74.2%, up 310 basis points year over year; gross profit of $164.5 million included a one-time tariff refund benefit of about $3.1 million. GAAP net loss was $29.9 million, or $0.90 per diluted share, versus $5.2 million, or $0.16, a year earlier; the quarter carried $49.8 million of litigation settlements and $6.6 million of business transformation costs. On the outlook: FY2026 revenue of $890 million to $895 million (raised from $880 million to $890 million), including about $16 million of expected VitalConnect revenue from the October 5 close through year-end; adjusted EBITDA margin of 15.5% to 16.0% (raised from 13.0% to 14.0%), inclusive of VitalConnect. Figures are for Q3 2026, as iRhythm reported them.
- Revenue
- $222M
- Net Income
- -$30M
- EPS
- $-0.90
- Total Assets
- $1.1B
- Operating Cash Flow
- $4M
Recent quarters
| Period | Revenue | Net Income | EPS | Operating Margin | Free Cash Flow |
|---|---|---|---|---|---|
| Q3 FY2026 | $222M | -$30M | -$0.90 | -14.69% | -$12M |
| Q2 FY2026 | $224M | -$381K | -$0.01 | -1.13% | $38M |
| Q1 FY2026 | $199M | -$14M | -$0.43 | -8.12% | -$33M |
| Q4 FY2025 | $209M | $6M | $0.17 | 4.2% | $14M |
| Q3 FY2025 | $193M | -$5M | -$0.16 | -4.37% | $20M |
Recent fiscal years
| Period | Revenue | Net Income | EPS | Operating Margin | Free Cash Flow |
|---|---|---|---|---|---|
| FY2025 | $747M | -$45M | -$1.39 | -7.68% | $35M |
| FY2024 | $592M | -$113M | -$3.63 | -19.52% | -$46M |
| FY2023 | $493M | -$123M | -$4.04 | -25.4% | -$91M |
Frequently asked questions
What was iRhythm's revenue last quarter?
iRhythm reported revenue of $221.6 million for Q3 FY2026, up 14.9% from the same period a year earlier.
Is iRhythm profitable?
Not in its most recent reported period. iRhythm reported a net loss of $29.9 million for Q3 FY2026, a net margin of -13.47% on revenue.
How has iRhythm's margin trended?
Operating margin was -14.69% in Q3 FY2026, compared with -4.37% in the same period a year earlier. The quarter by quarter series is on the SentiSense financials page.
How much free cash flow did iRhythm generate?
iRhythm generated free cash flow of -$11.5 million in Q3 FY2026, after capital expenditure.
Full income statement, balance sheet and cash flow for iRhythm Holdings, Inc. Common Stock on SentiSense, with up to forty quarters and twenty fiscal years of history.